ALCAM and breast carcinoma: King et al. [26] have shown that breast cancer cells, when overexpressing ALCAM, are increasingly trapped in the lung vasculature, partly reflected by an increase in tumour-endothelial interactions, which can be reduced by anti-ALCAM antibody [26,124].